Lv1
100 积分 2026-04-16 加入
Newly revised 2023 MDS response criteria
1个月前
已完结
TheEfficacyandSafetyofSelinexorinCombinationwithRuxolitinibinRuxolitinib-TreatedMyelofibrosisPatients：theInterimAnalysisofaProspectiveOpen-LabelMulticenterParallel-CohortPhase2Stud
1个月前
已关闭
Pharmacokinetic Study of Chidamide Concentration in Cerebrospinal Fluid and Plasma of Rats by LC-MS
1个月前
已完结
Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
2个月前
已完结
皖公网安备34019202002308
